MRNA expression of IFNγR was evaluated in human pancreatic carcinoid BON tumor cells (lane 3)

<p><b>Copyright information:</b></p><p>Taken from "A novel approach in the treatment of neuroendocrine gastrointestinal tumors: Additive antiproliferative effects of interferon-γ and meta-iodobenzylguanidine"</p><p>BMC Cancer 2004;4():23-23.</p><p>Published online 21 May 2004</p><p>PMCID:PMC442128.</p><p>Copyright © 2004 Höpfner et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</p> Neuroendocrine differentiated colorectal carcinoma cells (Colo320 DM) served as positive control for IFNγR (lane 4). β-actin was used as loading control (lane 1: BON, lane 2: Colo320 DM). PCR products were visualized by gel electrophoresis on an ethidium bromide-stained agarose gel. M: 100 bp DNA ladder